Switch Maintenance in Pancreatic

NCT05419479 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

46

Enrollment

OTHER

Sponsor class

Stopped Efficacy concerns.

Conditions

Pancreatic Cancer
Adenocarcinoma of the Pancreas
Squamous Cell Carcinoma of Pancreas
Adenosquamous Carcinoma of the Pancreas

Interventions

DRUG: ZIMBERELIMAB
DRUG: DOMVANALIMAB
DRUG: APX005M
DRUG: FOLFIRI

Sponsor

James Cleary, MD, PhD

Collaborators

Arcus Biosciences, Inc.
Lustgarten Foundation